A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway - Concepedia

Concepedia

Publication | Open Access

A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway

DOI Full Paper Access

39

Citations

64

References

2022

Year

Sae‐Bom Yoon, Hyowon Hong, Hee‐Jong Lim, Ji Hye Choi, Yoon Pyo Choi, Seong Wook Seo, Hyuk Woo Lee, Chong Hak Chae, Woo-Kyu Park, Hyun Young Kim,

Acta Pharmaceutica Sinica B

References

	Year	Citations

Page 1